With a specialty in solid oral dosage forms and experience in both immediate and controlled release tablets, Andy's expertise spans proprietary technologies and innovative solutions. Holding a US patent for a novel pharmaceutical powder flow assessment approach, his commitment to process optimization through Design for Manufacture, PAT, and experimental design has been a hallmark of his career.
Prior to this, he held a key role as Senior Pharmaceutics Scientist at GlaxoSmithKline, where he led projects involving new chemical entities in varying dosage forms. |
No comments:
Post a Comment